Kevin Drew Nabholz - Net Worth and Insider Trading
Kevin Drew Nabholz Net Worth
The estimated net worth of Kevin Drew Nabholz is at least $7 Million dollars as of 2024-09-24. Kevin Drew Nabholz is the Director of Knight Therapeutics Inc and owns about 1,200,000 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $7 Million. Details can be seen in Kevin Drew Nabholz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin Drew Nabholz has not made any transactions after 2019-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kevin Drew Nabholz
Kevin Drew Nabholz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin Drew Nabholz owns 1 companies in total, including Knight Therapeutics Inc (TSX:GUD) .
Click here to see the complete history of Kevin Drew Nabholz’s form 4 insider trades.
Insider Ownership Summary of Kevin Drew Nabholz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-08-09 | Director |
Kevin Drew Nabholz Latest Holdings Summary
Kevin Drew Nabholz currently owns a total of 1 stock. Kevin Drew Nabholz owns 1,200,000 shares of Knight Therapeutics Inc (TSX:GUD) as of August 9, 2019, with a value of $7 Million.
Latest Holdings of Kevin Drew Nabholz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-08-09 | 1,200,000 | 5.91 | 7,092,000 |
Holding Weightings of Kevin Drew Nabholz
Kevin Drew Nabholz Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin Drew Nabholz has made a total of 0 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years. The most-recent trade in Knight Therapeutics Inc is the acquisition of 600,000 shares on August 9, 2019, which cost Kevin Drew Nabholz around $5 Million.
Insider Trading History of Kevin Drew Nabholz
- 1
Kevin Drew Nabholz Trading Performance
GuruFocus tracks the stock performance after each of Kevin Drew Nabholz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin Drew Nabholz is 8.85%. GuruFocus also compares Kevin Drew Nabholz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin Drew Nabholz within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin Drew Nabholz's insider trading performs compared to the benchmark.
Performance of Kevin Drew Nabholz
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.7 | | | | | |
| Relative Return to S&P 500(%) | 1.65 | | | | | |
Kevin Drew Nabholz Ownership Network
Kevin Drew Nabholz Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
Kevin Drew Nabholz is the Director of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Senior Officer Amal Khouri , Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman , and 10% Security Holder Sime Armoyan .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, Kevin Drew Nabholz made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 1,479,900 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .
In summary, during the past 3 months, insiders sold 45,000 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 0 shares, with a net sale of 45,000 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 1,734,100 shares were bought by its insiders, resulting in a net purchase of 1,419,900 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
Kevin Drew Nabholz Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin Drew Nabholz. Currently GuruFocus does not have mailing address information for Kevin Drew Nabholz.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
